Freshfields advises on listing of Blue Moon Group Holdings Limited in Hong Kong

The Freshfields team advising on the transaction was led by partners Grace Huang and Calvin Lai.

Freshfields berät HCOB bei dem Verkauf der Unternehmenszentrale

Die Federführung übernahmen Dr. Patrick Cichy und Dr. Johannes Conradi.

Freshfields advises Permira on its investment in Catawiki

Closing of the transaction is subject to customary regulatory approvals.

Freshfields Represents AstraZeneca in $39B Acquisition of Alexion – Largest Acquisition of US Company and Largest Acquisition Financing in 2020

Freshfields mounted a global team to handle corporate/M&A, finance, compensation and benefits, tax, antitrust, foreign investment, IP, data privacy, securities law, and capital markets aspects of this historic merger. 

Freshfields report explores issues that will dominate 2021 U.S. corporate board agendas during the recovery era

Board Memo 2021: A Guide to Taking on the Recovery Era provides directors of U.S. public companies with practical insight for navigating ESG considerations, the upcoming 2021 proxy season, the M&A and activism landscape and a shifting enforcement, regulatory and litigation environment.

Freshfields berät MYR zur Übernahme durch Gilead

Das Team von Freshfields wurde von den Partnern Dr. Jochen Dieselhorst und Dr. Lars Meyer sowie Dr. Eva-Maria Hoyler (Principal Associate) geleitet.

Freshfields advises Allied Universal on its recommended £3.8bn cash offer for G4S

The transaction was announced on 8 December 2020 and is expected to close in the first quarter of 2021.

Freshfields advises MYR on acquisition by Gilead

The Freshfields team was led by Jochen Dieselhorst, Lars Meyer and Eva-Maria Hoyler. 

Freshfields advises The Carlyle Group on the acquisition of Acrotec Group

Freshfields a conseillé The Carlyle Group dans le cadre de l’acquisition d’Acrotec Group